Company intelligence / Profile preview
Hofseth BioCare ASA
- Ownership
- Private
- Development stage
- Commercial
Overview
Hofseth BioCare has demonstrated in exploratory human studies that its OmeGo® whole salmon oil provides broad inflammation-resolving effects and improved interferon response. ProGo® has shown improved iron metabolism in humans. Larger clinical trials are ongoing or planned for respiratory health benefits of OmeGo®. The company’s biotech spinout HBC Immunology has a lead program in prostate cancer entering the clinic.
- Therapeutic areas
- OtherPulmonologyGastroenterologyHematology
- Modalities
- Bioactive peptides (from salmon protein hydrolysate)Marine-derived oils (whole salmon oil)Collagen and mineral complexes (from salmon bone)Peptide fractions as medical food
- Industry
- Biotech
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →Partnerships
Beyond the preview
Go deeper on Hofseth BioCare ASA.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hofseth BioCare ASA.